Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases is a research paper published in Frontiers in Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Medical Research Council
Grant: MR/R025096/1
Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for ARDS.
Medical Research Council
Grant: MR/S009426/1
"The role of extracellular vesicle miRNAs in Mesenchymal Stem Cells' effects on macrophage modulation in ARDS"
Irish Research Council
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1R21EB024329-01
Decellularized Avian Lungs for Use in Pulmonary Therapeutics
European Commission
Grant: 713406
REspiratory Science Promoted by International Research Exchanges 3
National Institutes of Health
Grant: 5R01HL127144-02
Optimizing Functional Recellularization of Acellular Human Lung Scaffolds
FWCI
1.75
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals